about
Mouse models of atherosclerosis: a historical perspective and recent advances.Multi-omics approaches to disease.Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.miR-155 Promotes ox-LDL-Induced Autophagy in Human Umbilical Vein Endothelial Cells.Differential Expression of MicroRNAs in Endarterectomy Specimens Taken from Patients with Asymptomatic and Symptomatic Carotid Plaques.Identification of Blood Let-7e-5p as a Biomarker for Ischemic StrokeAtherosclerosis: Successes, Surprises, and Future Challenges.Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosisMicroRNA-181b Controls Atherosclerosis and Aneurysms Through Regulation of TIMP-3 and Elastin.Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk.Inhibition of Mef2a Enhances Neovascularization via Post-transcriptional Regulation of 14q32 MicroRNAs miR-329 and miR-494.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.MicroRNAs in dysfunctional adipose tissue: cardiovascular implications.The role of miRNAs in cardiovascular disease risk factors.microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.Transcriptomic Signature of Atherosclerosis in the Peripheral Blood: Fact or Fiction?The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection.Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.Investigational therapies for hypercholesterolemia.MicroRNA regulation of extracellular matrix components in the process of atherosclerotic plaque destabilization.microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.A Concise Review of MicroRNA Exploring the Insights of MicroRNA Regulations in Bacterial, Viral and Metabolic Diseases.Adventitial SCA-1+ Progenitor Cell Gene Sequencing Reveals the Mechanisms of Cell Migration in Response to HyperlipidemiaIntegrating microRNA and messenger RNA expression profiles in a rat model of deep vein thrombosis.Circulating microRNAs as potential biomarkers for coronary plaque rupture.miRNA-197 and miRNA-223 and cardiovascular death in coronary artery disease patients.The interplay between genetics, epigenetics and environment in modulating the risk of coronary heart disease.MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesisEffect of Wenxin Granules on Gap Junction and MiR-1 in Rats with Myocardial Infarction.NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation.miRNA Expression Profile and Effect of Wenxin Granule in Rats with Ligation-Induced Myocardial Infarction.The potential inhibitory effects of miR‑19b on vulnerable plaque formation via the suppression of STAT3 transcriptional activity.miRNA Expression Profile and Effect of Wenxin Granule in Rats with Ligation-Induced Myocardial Infarction.MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations.Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration.miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways.The role of the miR-148/-152 family in physiology and disease.Influence of sex on the number of circulating endothelial microparticles and microRNA expression in middle-aged adults.LncRNAs in vascular biology and disease.MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers?
P2860
Q30238973-03FABDE8-C367-4C90-9B77-079121D89DCCQ33640903-C2AA6DF1-60E7-4CCB-B9F8-7AE702C0A0CBQ33739176-5FFEB014-DBD6-47E0-8571-DF6CF7CD2598Q33809004-65FBAD47-04CB-4705-8193-D224820C201CQ36133951-91F2DA01-3893-458C-A3FC-579766BF092DQ36173055-A0E16136-85F6-42D3-9029-C38BA9354E79Q36602802-57F72DC4-4D9E-4BFF-8BEE-FC26B01DACB7Q37060780-2752F49E-BE56-4B3D-9EBD-C24F745A90E4Q37558108-135ED6DE-C8AC-46ED-B3ED-039844B6D6AFQ37640216-FA36D2B9-1F11-46C6-855A-59008044E42BQ38287926-E19A3233-429B-4FC7-9FFC-7EB67DE36E0BQ38681468-8689A553-34A2-499E-8ADC-B4AFC56FC34AQ38683783-1D2711A9-9D0E-4ABE-9594-CE9EECA4B6E0Q38815760-017A2C31-415C-463A-B637-EF9E701B5300Q38827780-11840C56-58B4-4F92-BB71-A1EBBF20C2BBQ38999334-48C4AECF-965D-485D-8AE6-CB331C8152D1Q39132986-62D5FFAF-21D7-4F1B-8E40-A7531FA9DCFDQ39190427-D9BD651F-4260-4CE3-96B6-BA58D0A35339Q39215123-D798A592-3C4D-4292-9C0F-EA554B6542E0Q39261257-CC988D8F-00B0-4ED5-A36F-3EE74C241E30Q39403789-0E5E56CA-647C-4AC4-B17C-2511F48CB4DDQ40051692-677323E8-74BE-41FC-8996-C795B30145D6Q41326807-AA5CC0E3-7CFB-4839-A8E7-4A6BC2D3F38DQ41352432-51062595-C762-442B-820A-E65A223680ABQ41471482-1F30F523-B324-4859-81D1-9051A3BA398DQ42177614-A1B83762-77C0-464E-B041-38D2E6D04D78Q42332676-BA38D927-470D-42F9-96BE-4A14447E250BQ42362245-6312D2C5-C132-4387-9764-ED1BAE44506CQ45942632-8D7E3A61-5F0B-4D19-9707-2DC1F53D177DQ46257036-3F1ADA9D-1E29-4C97-B7F0-22855A3A843CQ47285038-060ABB53-E756-443F-8216-0EB988AD80C0Q47365610-BB26CC99-79DC-4095-8E39-364783496530Q47686878-1ED065F3-8142-4000-ABA2-F019AB81C922Q47802041-037043A9-0A04-435E-A84F-71F7BFF3F648Q47838522-26992F6D-BF56-49E2-81AD-30475B153E40Q47905950-1B30B19C-D586-4D1C-889D-3F423A7E3E7AQ48111289-1B429613-7B16-4114-909E-8B32D0CE979BQ48346587-0542E46A-7A69-474C-BFFC-CCBC3DE95F81Q50096190-EFD415EA-91A1-4388-88E0-F23DB19FA507Q50101441-6485FFA0-C175-4C5F-8DFF-589348672C4F
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
MicroRNA Regulation of Atherosclerosis.
@ast
MicroRNA Regulation of Atherosclerosis.
@en
type
label
MicroRNA Regulation of Atherosclerosis.
@ast
MicroRNA Regulation of Atherosclerosis.
@en
prefLabel
MicroRNA Regulation of Atherosclerosis.
@ast
MicroRNA Regulation of Atherosclerosis.
@en
P2860
P1433
P1476
MicroRNA Regulation of Atherosclerosis.
@en
P2093
Mark W Feinberg
P2860
P304
P356
10.1161/CIRCRESAHA.115.306300
P577
2016-02-01T00:00:00Z